Does Adjuvant Steroid Therapy Post-Kasai Portoenterostomy Improve Outcome of Biliary Atresia? Systematic Review and Meta-analysis

Overview

Journal Can J Gastroenterol

Specialty Gastroenterology

Date 2011 Sep 14

PMID 21912769

Citations 18

Authors

Ahmed Sarkhy

Richard A Schreiber

Ruth A Milner

Collin C Barker

Affiliations

Soon will be listed here.

Abstract

Background: The role of adjuvant steroid therapy in the postoperative management of patients with biliary atresia (BA) is unclear.

Objective: To systematically review the literature and perform a meta-analysis to determine the efficacy of adjuvant steroid therapy post-Kasai portoenterostomy (KP) on BA outcome.

Methods: A systematic review and meta-analysis of randomized trials and⁄or observational studies that examined the role of steroids on BA outcomes published between January 1969 and June 2010 was conducted. Studies were identified using the Medline, PubMed, EMBASE and Cochrane databases.

Results: Sixteen observational studies and one randomized controlled trial (RCT) were found. Four of the 16 observational studies (160 participants) and the RCT (73 participants) met the entry criteria and were eligible to be included in the analysis. There was no statistically significant difference in the effect of steroids either on normalizing serum bilirubin levels at six months (pooled OR 1.48 [95% CI 0.67 to 3.28]) or in delaying the need for early liver transplantation (within the first year post-KP (pooled OR 0.59 [95% CI 0.21 to 1.72]).

Conclusion: The present meta-analysis did not find a significant effect of steroid over standard therapy, either in normalizing serum bilirubin levels at six months or at delaying the need for early liver transplantation post-KP. RCT studies of sufficient size and comprehensive design using high-dose steroids are needed to determine the effectiveness of steroids on the short and intermediate post-KP outcomes for BA patients.

Citing Articles

Predictors of biliary atresia outcome: Saudi National Study (2000 - 2018).

Abanemai M, AlEdreesi M, Al Sarkhy A, Saadah O, Alhebbi H, Bader R Saudi J Gastroenterol. 2023; 29(5):286-294.

PMID: 37787348 PMC: 10645002. DOI: 10.4103/sjg.sjg_512_22.

Customized Postoperative Therapy Improves Bile Drainage in Biliary Atresia: A Single Center Preliminary Report.

Pandurangi S, Kim S, Asai A, Bondoc A, Balistreri W, Campbell K J Pediatr Surg. 2022; 58(8):1483-1488.

PMID: 36496264 PMC: 10846645. DOI: 10.1016/j.jpedsurg.2022.10.050.

Peri-Operative Liver Fibrosis and Native Liver Survival in Pediatric Patients with Biliary Atresia: A Systematic Review and Meta-Analysis.

Jahangirnia A, Oltean I, Nasr Y, Islam N, Weir A, de Nanassy J Pediatr Gastroenterol Hepatol Nutr. 2022; 25(5):353-375.

PMID: 36148293 PMC: 9482824. DOI: 10.5223/pghn.2022.25.5.353.

Short- and long-term outcomes after Kasai operation for type III biliary atresia: Twenty years of experience in a single tertiary Egyptian center-A retrospective cohort study.

Gad E, Kamel Y, Salem T, Ali M, Sallam A Ann Med Surg (Lond). 2021; 62:302-314.

PMID: 33552489 PMC: 7847812. DOI: 10.1016/j.amsu.2021.01.052.

Evaluation of Perioperative Complications in the Management of Biliary Atresia.

Du M, Wang J, Tang Y, Jiang J, Chen G, Huang Y Front Pediatr. 2020; 8:460.

PMID: 33014917 PMC: 7493688. DOI: 10.3389/fped.2020.00460.

References

Petersen C, Harder D, Melter M, Becker T, Wasielewski R, Leonhardt J . Postoperative high-dose steroids do not improve mid-term survival with native liver in biliary atresia. Am J Gastroenterol. 2008; 103(3):712-9. DOI: 10.1111/j.1572-0241.2007.01721.x. View

Dillon P, Owings E, Cilley R, Field D, Curnow A, Georgeson K . Immunosuppression as adjuvant therapy for biliary atresia. J Pediatr Surg. 2001; 36(1):80-5. DOI: 10.1053/jpsu.2001.20013. View

Meyers R, Book L, OGorman M, Jackson W, Black R, Johnson D . High-dose steroids, ursodeoxycholic acid, and chronic intravenous antibiotics improve bile flow after Kasai procedure in infants with biliary atresia. J Pediatr Surg. 2003; 38(3):406-11. DOI: 10.1053/jpsu.2003.50069. View

Sokol R, Mack C . Etiopathogenesis of biliary atresia. Semin Liver Dis. 2001; 21(4):517-24. DOI: 10.1055/s-2001-19032. View

Escobar M, Jay C, Brooks R, West K, Rescorla F, Molleston J . Effect of corticosteroid therapy on outcomes in biliary atresia after Kasai portoenterostomy. J Pediatr Surg. 2006; 41(1):99-103. DOI: 10.1016/j.jpedsurg.2005.10.072. View

Chitsaz E, Schreiber R, Collet J, Kaczorowski J . Biliary atresia: the timing needs a changin'. Can J Public Health. 2010; 100(6):475-7. PMC: 6973595. View

Chung H, Wong K, Lan L, Tam P . Evaluation of a standardized protocol in the use of steroids after Kasai operation. Pediatr Surg Int. 2008; 24(9):1001-4. DOI: 10.1007/s00383-008-2200-2. View

Karrer F, Lilly J . Corticosteroid therapy in biliary atresia. J Pediatr Surg. 1985; 20(6):693-5. DOI: 10.1016/s0022-3468(85)80026-9. View

Sokol R, Shepherd R, Superina R, Bezerra J, Robuck P, Hoofnagle J . Screening and outcomes in biliary atresia: summary of a National Institutes of Health workshop. Hepatology. 2007; 46(2):566-81. PMC: 3888317. DOI: 10.1002/hep.21790. View

10.

DerSimonian R, Laird N . Meta-analysis in clinical trials. Control Clin Trials. 1986; 7(3):177-88. DOI: 10.1016/0197-2456(86)90046-2. View

11.

Shneider B, Brown M, Haber B, Whitington P, Schwarz K, Squires R . A multicenter study of the outcome of biliary atresia in the United States, 1997 to 2000. J Pediatr. 2006; 148(4):467-474. DOI: 10.1016/j.jpeds.2005.12.054. View

12.

Shimadera S, Iwai N, Deguchi E, Kimura O, Ono S, Fumino S . Significance of ductal plate malformation in the postoperative clinical course of biliary atresia. J Pediatr Surg. 2008; 43(2):304-7. DOI: 10.1016/j.jpedsurg.2007.10.023. View

13.

Stringer M, Davison S, Rajwal S, McClean P . Kasai portoenterostomy: 12-year experience with a novel adjuvant therapy regimen. J Pediatr Surg. 2007; 42(8):1324-8. DOI: 10.1016/j.jpedsurg.2007.03.026. View

14.

Balistreri W, Grand R, Hoofnagle J, Suchy F, Ryckman F, Perlmutter D . Biliary atresia: current concepts and research directions. Summary of a symposium. Hepatology. 1996; 23(6):1682-92. DOI: 10.1002/hep.510230652. View

15.

Schreiber R, Barker C, Roberts E, Martin S, Alvarez F, Smith L . Biliary atresia: the Canadian experience. J Pediatr. 2007; 151(6):659-65, 665.e1. DOI: 10.1016/j.jpeds.2007.05.051. View

16.

Shimadera S, Iwai N, Deguchi E, Kimura O, Fumino S, Ono S . The significance of steroid therapy after hepatoportoenterostomy in infants with biliary atresia. Eur J Pediatr Surg. 2007; 17(2):100-3. DOI: 10.1055/s-2007-965120. View

17.

Sutton A, Duval S, Tweedie R, Abrams K, Jones D . Empirical assessment of effect of publication bias on meta-analyses. BMJ. 2000; 320(7249):1574-7. PMC: 27401. DOI: 10.1136/bmj.320.7249.1574. View

18.

Jadad A, Moore R, Carroll D, Jenkinson C, Reynolds D, Gavaghan D . Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Control Clin Trials. 1996; 17(1):1-12. DOI: 10.1016/0197-2456(95)00134-4. View

19.

Vejchapipat P, Passakonnirin R, Sookpotarom P, Chittmittrapap S, Poovorawan Y . High-dose steroids do not improve early outcome in biliary atresia. J Pediatr Surg. 2007; 42(12):2102-5. DOI: 10.1016/j.jpedsurg.2007.08.038. View

20.

Muraji T, Higashimoto Y . The improved outlook for biliary atresia with corticosteroid therapy. J Pediatr Surg. 1997; 32(7):1103-6; discussion 1106-7. DOI: 10.1016/s0022-3468(97)90408-5. View